APA Citatie

Lashley, D., Palace, J., Jayawant, S., Robb, S., & Beeson, D. (2010). Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7 [Image: See text]. American Academy of Neurology.

Chicago Style citaat

Lashley, D., J. Palace, S. Jayawant, S. Robb, en D. Beeson. Ephedrine Treatment in Congenital Myasthenic Syndrome Due to Mutations in DOK7 [Image: See Text]. American Academy of Neurology, 2010.

MLA citatie

Lashley, D., et al. Ephedrine Treatment in Congenital Myasthenic Syndrome Due to Mutations in DOK7 [Image: See Text]. American Academy of Neurology, 2010.